258 related articles for article (PubMed ID: 12672192)
41. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
Tzaneva S; Volc-Platzer B; Kittler H; Hönigsmann H; Tanew A
Br J Dermatol; 2008 May; 158(5):1050-4. PubMed ID: 18341657
[TBL] [Abstract][Full Text] [Related]
42. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.
Selmi C; Ceribelli A; Generali E; Scirè CA; Alborghetti F; Colloredo G; Porrati L; Achenza MI; De Santis M; Cavaciocchi F; Massarotti M; Isailovic N; Paleari V; Invernizzi P; Matthias T; Zucchi A; Meroni PL
Autoimmun Rev; 2016 Feb; 15(2):162-6. PubMed ID: 26524640
[TBL] [Abstract][Full Text] [Related]
43. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
44. Anti-nuclear antibodies as predictor of outcome in a multi-center cohort of Italian children and adolescents with Raynaud's phenomenon.
Falcini F; Rigante D; Candelli M; Martini G; Corona F; Petaccia A; La Torre F; Raffaele CG; Matucci Cerinic M
Clin Rheumatol; 2015 Jan; 34(1):167-9. PubMed ID: 25428518
[TBL] [Abstract][Full Text] [Related]
45. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
46. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series.
West M; Jasin HE; Medhekar S
Semin Arthritis Rheum; 2006 Jun; 35(6):344-8. PubMed ID: 16765710
[TBL] [Abstract][Full Text] [Related]
47. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
49. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
[TBL] [Abstract][Full Text] [Related]
50. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
51. The "submerged" connective tissue diseases.
Scagliusi P; Tortorelli E; D'Amore M
Panminerva Med; 2002 Sep; 44(3):237-41. PubMed ID: 12094139
[TBL] [Abstract][Full Text] [Related]
52. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
Abbasi SY; Milhem M; Zaru L
Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983
[TBL] [Abstract][Full Text] [Related]
53. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
[TBL] [Abstract][Full Text] [Related]
54. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance.
Imazio M; Brucato A; Doria A; Brambilla G; Ghirardello A; Romito A; Natale G; Palmieri G; Trinchero R; Adler Y
Int J Cardiol; 2009 Aug; 136(3):289-93. PubMed ID: 18674829
[TBL] [Abstract][Full Text] [Related]
55. Understanding antinuclear antibodies.
Pertusi RM; Rubin BR
J Am Osteopath Assoc; 1991 Jun; 91(6):563-4, 567-9. PubMed ID: 1874653
[TBL] [Abstract][Full Text] [Related]
56. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
[TBL] [Abstract][Full Text] [Related]
57. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.
Lazzerini PE; Capecchi PL; Guideri F; Bellisai F; Selvi E; Acampa M; Costa A; Maggio R; Garcia-Gonzalez E; Bisogno S; Morozzi G; Galeazzi M; Laghi-Pasini F
Am J Cardiol; 2007 Sep; 100(6):1029-34. PubMed ID: 17826392
[TBL] [Abstract][Full Text] [Related]
58. Raynaud's phenomenon: clinical spectrum of 118 patients.
De Angelis R; Del Medico P; Blasetti P; Cervini C
Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
[TBL] [Abstract][Full Text] [Related]
60. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease.
Deane PM; Liard G; Siegel DM; Baum J
Pediatrics; 1995 Jun; 95(6):892-5. PubMed ID: 7761217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
